SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the second quarter and six months ended June 30, 2019 and provided a corporate update.

LAS VEGAS, Aug. 7, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyund

BOSTON, Aug. 7, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") announced today that

LOS ANGELES, Aug. 7, 2019 /PRNewswire/ -- Based in Southern California, the surrogacy company Joy of Life was established two years ago. With hard work and meticulous care, a group of enthusiastic and passionate women focused on growing a company that would fulfill the dreams of intended parents with the help of strong surroga

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Cambrex Corporation (NYSE: CBM) ("Cambrex") breached their fiduciary duties in connection with the proposed sale of the Company to private equity firm Permira.On August 7, 2019, C

MINNEAPOLIS, Aug. 7, 2019 /PRNewswire/ -- Today, the leaders from the Manova Global Summit on the Future of Health announced that Jane Fonda, Academy Award-winning actress, Co-Founder of the Women's Media Center, Founder of the Georgia Campaign for Adolescent Power & Potential, is participating in the Manova Summit, on

The Co-operators and BDC Capital co-lead investment that will expand AI-driven infectious disease global early warning system TORONTO, August 7, 2019 /PRNewswire/ - BlueDot, a digital health company that uses big data analytics to track and anticipate the spread of the world's most dangerous infectious diseases, announced today that it

GERMANTOWN, Md., Aug. 7, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR) ("Neuralstem" or the  Company") today announced that on August 6, 2019, it received a letter from the Office of General Counsel of The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that the Nasdaq Hearings Panel (the "Panel") has granted the Company'

NEW HAVEN, Conn., Aug. 7, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases today reported completion of enrollment in its pivotal Phase 3 preventive treatment of migraine trial with rimegepant, its lead or

MENLO PARK, Calif., Aug. 7, 2019 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced that Jessica Holmes, Brian Regan and Jim Sluck have joined the company as